US 7671174
Ligand to GPR8
granted A61KA61K38/00A61P
Quick answer
US patent 7671174 (Ligand to GPR8) held by Takeda Pharmaceutical Company Limited expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61P, A61P1/14, A61P3/04